Clinical trials
Phase 1 Hodgkin Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2016 | 1 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 3 |
| Cellectar Biosciences, Inc. | 1 |
| Children's Oncology Group | 1 |
| London Health Sciences Centre | 1 |
| National Cancer Institute (NCI) | 1 |
| Pfizer | 1 |
| Seagen Inc. | 1 |
| Shattuck Labs, Inc. | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 11 |
| Lymphoma | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, T-Cell, Cutaneous | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Burkitt Lymphoma | 3 |
| Hematologic Neoplasms | 3 |
| Immunoblastic Lymphadenopathy | 3 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.